Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roslin Cell Sciences is a UK biotechnology company focused on human pluripotent stem cell and induced pluripotent stem cell technologies for research, drug discovery, and cell therapy development. The company appears to operate primarily as a platform and services business rather than as a developer of its own clinical therapeutic pipeline. It is part of the broader Roslin Cells group and is historically linked to the Roslin Institute in Scotland. Roslin Cell Sciences has been associated with high-quality iPSC-based research services, disease-relevant cell models, and cell line generation capabilities for partners in pharma and biotech. The business is life-science focused, but available public information does not show an independent clinical-stage drug pipeline under this specific legal entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roslin Cell Sciences.